Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioXcel Therapeutics (BTAI) Asset Utilization Ratio (2022 - 2025)

Historic Asset Utilization Ratio for BioXcel Therapeutics (BTAI) over the last 4 years, with Q3 2025 value amounting to 0.02.

  • BioXcel Therapeutics' Asset Utilization Ratio fell 4648.12% to 0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year decrease of 4648.12%. This contributed to the annual value of 0.04 for FY2024, which is 30970.85% up from last year.
  • Latest data reveals that BioXcel Therapeutics reported Asset Utilization Ratio of 0.02 as of Q3 2025, which was down 4648.12% from 0.03 recorded in Q2 2025.
  • BioXcel Therapeutics' 5-year Asset Utilization Ratio high stood at 0.05 for Q4 2024, and its period low was 0.01 during Q4 2022.
  • Its 4-year average for Asset Utilization Ratio is 0.02, with a median of 0.02 in 2025.
  • As far as peak fluctuations go, BioXcel Therapeutics' Asset Utilization Ratio soared by 53221.72% in 2024, and later tumbled by 4648.12% in 2025.
  • Over the past 4 years, BioXcel Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.01 in 2022, then soared by 393.2% to 0.02 in 2023, then surged by 227.82% to 0.05 in 2024, then crashed by 58.99% to 0.02 in 2025.
  • Its Asset Utilization Ratio stands at 0.02 for Q3 2025, versus 0.03 for Q2 2025 and 0.05 for Q1 2025.